HLX05
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HLX05, covering 2024-06-17 to 2025-07-08. Get the full timeline:
Most recent: Clinical Trial Update: Phase I PK Comparison of HLX05 vs. Erbitux® in Healthy Chinese Males: Safety, Immunogenicity, and Pharmacokinetics [Phase 1]